FDA Inspection 947992 — GlaxoSmithKline Biologicals Kft.
The FDA completed an inspection of GlaxoSmithKline Biologicals Kft. on Oct 6, 2015 in Godollo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 6, 2015
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Godollo (Hungary)